Cargando…
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic disease considered to be triggered by viral infections in a majority of cases. Symptoms overlap largely with those of post-acute sequelae of COVID-19/long-COVID implying common pathogenetic mechanisms. SARS-CoV-2 in...
Autores principales: | Apostolou, Eirini, Rizwan, Muhammad, Moustardas, Petros, Sjögren, Per, Bertilson, Bo Christer, Bragée, Björn, Polo, Olli, Rosén, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630598/ https://www.ncbi.nlm.nih.gov/pubmed/36341457 http://dx.doi.org/10.3389/fimmu.2022.949787 |
Ejemplares similares
-
Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosa
por: Hannestad, Ulf, et al.
Publicado: (2023) -
Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Bragée, Björn, et al.
Publicado: (2020) -
Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies
por: Nilsson, Isabell, et al.
Publicado: (2020) -
Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model
por: Blomberg, Jonas, et al.
Publicado: (2018) -
Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Blomberg, Jonas, et al.
Publicado: (2019)